Rachid Berair

1.1k total citations
23 papers, 710 citations indexed

About

Rachid Berair is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Rachid Berair has authored 23 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Pulmonary and Respiratory Medicine and 3 papers in Immunology. Recurrent topics in Rachid Berair's work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Rachid Berair is often cited by papers focused on Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Rachid Berair collaborates with scholars based in United Kingdom, Switzerland and United States. Rachid Berair's co-authors include Christopher E. Brightling, Ruth Saunders, Ruth Hartley, Ian Pavord, Salman Siddiqui, Amisha Singapuri, Sherif Gonem, Richard Kay, Fay Hollins and Andrew J. Wardlaw and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Science Translational Medicine and British Journal of Pharmacology.

In The Last Decade

Rachid Berair

21 papers receiving 705 citations

Peers

Countries citing papers authored by Rachid Berair

Since Specialization

Citations

This map shows the geographic impact of Rachid Berair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachid Berair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachid Berair more than expected).

Fields of papers citing papers by Rachid Berair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachid Berair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachid Berair. The network helps show where Rachid Berair may publish in the future.

Co-authorship network of co-authors of Rachid Berair

This figure shows the co-authorship network connecting the top 25 collaborators of Rachid Berair. A scholar is included among the top collaborators of Rachid Berair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachid Berair. Rachid Berair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibrocyte localisation to the ASM bundle in asthma: bidirectional effects on cell phenotype and behaviour 2020 ·Clinical & Translational Immunology ·Ruth Saunders, Davinder Kaur, Dhananjay Desai, Rachid Berair, Latifa Chachi, R. Thompson, Salman Siddiqui, Christopher E. Brightling	8
2	Prostaglandin D2 type 2 receptor antagonism reduces airway smooth muscle mass in asthma: mechanistic insights from in vitro and computational models 2019 ·The Novartis Repository (Novartis) ·(unknown), Himanshu Kaul, Rachid Berair, Sherif Gonem, Amisha Singapuri, Amanda Sutcliffe, Latifa Chachi, Michael Biddle, Davinder Kaur, Michelle Bourne, Ian Pavord, Andrew J. Wardlaw, Salman Siddiqui, Bindi S. Brook, R. H. Smallwood, Christopher E. Brightling	0
3	Reducing pathway length in lung cancer by multidisciplinary intervention: Wolverhampton Intervention in Lung cancer Daily, ‘The WILD project’ 2019 ·Lung Cancer ·(unknown), Rachid Berair, (unknown), (unknown), Kirk Tanner, (unknown)	1
4	DP ₂ antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment 2019 ·Science Translational Medicine ·Ruth Saunders, Himanshu Kaul, Rachid Berair, Sherif Gonem, Amisha Singapuri, Amanda Sutcliffe, Latifa Chachi, Michael Biddle, Davinder Kaur, Michelle Bourne, Ian Pavord, Andrew J. Wardlaw, Salman Siddiqui, Richard Kay, Bindi S. Brook, R. H. Smallwood, Christopher E. Brightling	54
5	In vitro,in silicoandin vivostudy challenges the impact of bronchial thermoplasty on acute airway smooth muscle mass loss 2018 ·European Respiratory Journal ·Igor L. Chernyavsky, Richard Russell, Ruth Saunders, G E Morris, Rachid Berair, Amisha Singapuri, Latifa Chachi, Adel Mansur, Peter Howarth, Patrick Dennison, Rekha Chaudhuri, Stephen Bicknell, Felicity R. A. J. Rose, Salman Siddiqui, Bindi S. Brook, Christopher E. Brightling	34
6	Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling 2017 ·European Respiratory Journal ·Rachid Berair, Ruth Hartley, Vijay Mistry, Ajay Sheshadri, Sumit Gupta, Amisha Singapuri, Sherif Gonem, Richard P. Marshall, Ana R. Sousa, Aarti Shikotra, Richard Kay, Andrew J. Wardlaw, Peter Bradding, Salman Siddiqui, Mario Castro, Christopher E. Brightling	31
7	Fevipiprant (qaw039) Reduces Airway Smooth Muscle Mass In Asthma Via Antagonism Of The Prostaglandin D2 Receptor 2 (dp2) 2017 ·Ruth Saunders, Himanshu Kaul, Rachid Berair, Amisha Singapuri, (unknown), Latifa Chachi, Michael Biddle, Amanda Sutcliffe, (unknown), Gerald Bacher, Michelle Bourne, Ian Pavord, Andrew J. Wardlaw, (unknown), Richard Kay, Bindi S. Brook, R. H. Smallwood, Christopher E. Brightling	4
8	Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism 2017 ·Ruth Saunders, Himanshu Kaul, Rachid Berair, Amisha Singapuri, Igor L. Chernyavsky, Latifa Chachi, Michael Biddle, Amanda Sutcliffe, (unknown), Gerald Bacher, Michelle Bourne, Ian Pavord, Andrew J. Wardlaw, Salman Siddiqui, Richard Kay, Bindi S. Brook, R. H. Smallwood, Christopher E. Brightling	1
9	Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial 2016 ·The Lancet Respiratory Medicine ·Sherif Gonem, Rachid Berair, Amisha Singapuri, Ruth Hartley, (unknown), Gerald Bacher, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, Adel Mansur, Andrew J. Wardlaw, Salman Siddiqui, Richard Kay, Christopher E. Brightling	184
10	Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease 2016 ·Allergy ·Adam Wright, Chris Newby, Ruth Hartley, Vijay Mistry, Sumit Gupta, Rachid Berair, Katy M. Roach, Ruth Saunders, (unknown), M. Shelley, (unknown), Bethan Barker, Christopher E. Brightling	13
11	Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma 2016 ·British Journal of Pharmacology ·(unknown), Nikol Sullo, Maria Matteis, Giuseppe Spaziano, J. McDonald, Ruth Saunders, Lucy Woodman, Konrad Urbanek, Antonella De Angelis, Raffaele De Palma, Rachid Berair, Mitesh Pancholi, Vijay Mistry, Francesco Rossi, Renzo Guerrini, Girolamo Calò, Bruno D’Agostino, Christopher E. Brightling, David G. Lambert	25
12	Effect Of Qaw039, An Oral Prostaglandin D2 Receptor (dp2/crth2) Antagonist, Upon Sputum And Bronchial Eosinophilic Inflammation And Clinical Outcomes In Treatment-Resistant Asthma: A Phase 2a Randomized Placebo-Controlled Trial 2015 ·American Journal of Respiratory and Critical Care Medicine ·Rachid Berair, Sherif Gonem, Amisha Singapuri, Ruth Hartley, (unknown), Gerald Bacher, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, (unknown), Andrew J. Wardlaw, (unknown), Richard Kay, Christopher E. Brightling	6
13	LATE-BREAKING ABSTRACT: Effect of QAW039, an oral prostaglandin D2 receptor (DP2/CRTh2) antagonist, upon bronchial epithelial integrity in treatment-resistant asthma in a randomized, placebo controlled study 2015 ·Rachid Berair, Sherif Gonem, Amisha Singapuri, Ruth Hartley, (unknown), Gerald Bacher, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, Adel Mansur, Andrew J. Wardlaw, Salman Siddiqui, Richard Kay, Christopher E. Brightling	8
14	S132 Sputum And Bronchial Biopsy Expression Of 8-oxo-7, 8-dihydro-2'-deoxyguanosine (8-oxodg) In Asthma Is Related To Neutrophilic Inflammation And Poor Asthma Control 2014 ·Thorax ·(unknown), Vijay Mistry, Amisha Singapuri, Marcus S. Cooke, Rachid Berair, Christopher E. Brightling	0
15	Asthma Therapy and Its Effect on Airway Remodelling 2014 ·Drugs ·Rachid Berair, Christopher E. Brightling	68
16	Late-breaking abstract: Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTh2) antagonist QAWo39 in eosinophilic asthma 2014 ·Sherif Gonem, Rachid Berair, Amisha Singapuri, Ruth Hartley, (unknown), Gerald Bacher, Chengxing Lu, Björn Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, Adel Mansur, Andrew J. Wardlaw, Salman Siddiqui, Richard Kay, Christopher E. Brightling	6
17	Origins of increased airway smooth muscle mass in asthma 2013 ·BMC Medicine ·Rachid Berair, Ruth Saunders, Christopher E. Brightling	56
18	Rationale and Clinical Results of Inhibiting Interleukin-5 for the Treatment of Severe Asthma 2013 ·Current Allergy and Asthma Reports ·Rachid Berair, Ian Pavord	12
19	Airway Smooth Muscle Hypercontractility in Asthma 2013 ·PubMed ·Rachid Berair, Fay Hollins, Christopher E. Brightling	28
20	Piqûres de scorpion chez l'enfant. Expérience saoudienne 1995 ·Archives de Pédiatrie ·(unknown), Rachid Berair	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact